--- title: 'Senior Manager, Congress Planning & Management at Tonix Pharmaceuticals' canonical: 'https://feeny.ai/job/senior-manager-congress-planning-management-tonix-pharmaceuticals-berkeley-2r5mphhs7zk2' type: 'job' last_seen: '2026-09-09' --- # Senior Manager, Congress Planning & Management at Tonix Pharmaceuticals - **Company:** Tonix Pharmaceuticals - **Location:** Berkeley Heights, NJ - **Compensation:** $114k–$152k - **Posted:** 2026-07-24 - **Last confirmed live:** 2026-09-09 - **Apply:** https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4323656009 ## Job description Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit [www.tonixpharma.com](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D9p5FBvlzG2u-9NzVEDdUgRNdl57Mw08p4h9XviYYnbwVJ-X_DNEOeN4RdGA64IhTnk9R4lQWNXhq0g8TrvoRTCZSpqmowBapMZCbqP_sxm0%3D&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987080441%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=WrmW8ZuY9XRYJZM0BMPu3thoab5uVHnt9SqBNHIoDuU%3D&reserved=0) and follow the Company on [LinkedIn](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DbldblPUeLBo2VtrimIDsthVk4RaPH1sCjnDw18J2Q9UGKOYpi7kKsd6NuJ4rb7a1ocGevguAt4l_8t8TE5rfCP1YmSBTJO1HR9Uo9KAv_DEwtbEkJhm1CdLRAEbAUNB-&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987109283%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=dHRzyv5dfKFOhCroh809txjNcJOjNrBSQRyfSgHaIu8%3D&reserved=0) and [X](https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D0NgIEJjy96AytWlfgCqgqVv5cOeUVkGOTFS78koSy22XXOczOtXjxSorNUcN-uDTk4CYVQkJndgCk6o2RQBlKQ%3D%3D&data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987130654%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=frLcoK5ETOWzJq9lmvkirCS8HaHc2WCX%2Fg4ESMSdLgk%3D&reserved=0). *Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Congress Planning and Management is responsible for managing and executing commercial congress strategy in support of the company's portfolio and commercial objectives for Tonix Medicines, Inc. This role leads the planning, execution, and optimization of national and regional congresses activities that enhance product awareness, strengthen customer relationships, and support commercial growth. As a member of the Commercial Strategy team, this role will work cross-functionally with Marketing, Sales, Market Access, Medical Affairs, Corporate Communications, and external partners. This individual will drive congress strategy from concept through execution while ensuring exceptional customer engagement and operational excellence. The ideal candidate is a strategic, highly organized professional who thrives in a fast-paced biotechnology environment and enjoys balancing long-term planning with hands-on execution. This role will play a key part in supporting commercial launches and building Tonix's presence across industry meetings. Essential Functions: Congress Planning & Execution - Identify and maintain a comprehensive congress list of National, Regional, and Local congress - Inform Commercial Strategy annual planning recommendation for national, regional, and local congress opportunities that maximize customer engagement and return on investment. - Execute the annual commercial congress plan with cross functional team in alignment with brand strategic imperatives and brand priorities - Ensure collaboration with Commercial Leadership, Brand Marketing, Sales, Market Access, Training, Corporate Communications, and other key stakeholders for congress plan implementation - Monitor industry trends, competitor activities, and emerging engagement strategies to continuously improve commercial execution. - Maintain all aspects of congress planning and execution, including contracting, sponsorships, product theaters operations, and executive encounter support - Oversee logistics including registration, housing, travel, meeting space, shipping, and vendor management. - Serve as the commercial lead during congresses, ensuring flawless execution and issue resolution. - Develop and maintain a congress playbook and repository to ensure operational excellence, scalability, and reproducibility Cross-Functional Collaboration - Collaborate with Marketing, Sales, Market Access, Medical Affairs, Compliance, Legal, Corporate Communications, and Training to ensure congress activities support commercial objectives. - Coordinate booth staffing, customer meetings, executive schedules, and internal communications. - Ensure all promotional materials and congress activities comply with company policies and applicable regulations. Budget - Develop and manage congress budgets and support annual planning - Track timelines, budgets, and project deliverables across multiple congresses. - Identify opportunities to improve efficiency while maintaining a high-quality customer experience. Measurement & Continuous Improvement - Develop KPIs to evaluate congress effectiveness. - Lead post-congress debriefs and summarize customer insights, competitive intelligence, and engagement metrics. - Provide recommendations to improve future congress strategy and return on investment. - Develop and maintain best practices and standardized processes for commercial congress planning. Supervisory Responsibilities: - This role does not include direct people management but may provide day‑to‑day guidance, project leadership, or functional oversight to team members and cross‑functional partners. Necessary Skills and Abilities: - Ability to travel approximately 30–40%, including weekends - Strong understanding of pharmaceutical commercial operations and customer engagement strategies. - Excellent project management, organizational, and communication skills. - Highly skilled at vendor management and contract negotiation. Educational Requirements: - Bachelor's degree in Marketing, Business, Communications, Life Sciences, or a related field - Certified Meeting Professional (CMP), PMP, or similar certification highly preferred. ## Experience Requirements - Minimum of 3 years of pharmaceutical or biotechnology experience supporting commercial congresses, meetings, events, or customer engagement. - Experience supporting commercial product launches preferred. - Demonstrated experience leading national and international congress planning and execution. - Experience managing exhibit booths, sponsorships, promotional activities, customer events, and agency relationships. - Experience in specialty pharmaceuticals or biotechnology preferred. - Experience supporting commercial launches, marketing, and corporate communications highly preferred. - Experience with CRM, project management, and event management platforms highly preferred. - Experience measuring congress effectiveness using customer engagement and commercial metrics highly preferred. Salary Range $114,000—$152,000 USD *Please note that Tonix does not offer sponsorship for this role. Recruitment & Staffing Agencies Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes. ## Compensation & Benefits Tonix provides a comprehensive compensation and benefits package which includes: - Medical, Dental & Vision Insurance, Basic and Voluntary Life and AD&D Insurance, Short- and Long-Term Disability Insurance, Flexible Spending Accounts, Health Savings Account, and Employee Assistance Programs - Pet Insurance - Retirement Savings 401k with company match and annual discretionary stock options - Generous Paid Time Off, Sick Time, & Paid Holidays - Career Development and Training Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law.  In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment.  This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training.  Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law. ## About Tonix Pharmaceuticals ## Company Overview - **One-liner**: A fully-integrated biopharmaceutical company commercializing and developing innovative therapies for central nervous system disorders, immunology, infectious diseases, and rare diseases. - **Entity Type**: Public (NASDAQ: TNXP) - **Headquarters**: Berkeley Heights, New Jersey, United States (as indicated by zip code 07922 on the investor relations page) [ir.tonixpharma.com](https://ir.tonixpharma.com/) - **Founded**: Not publicly available from provided sources - **Founders**: Not publicly available from provided sources ## Core Business - **Primary industry/industries**: Biotechnology / Pharmaceuticals (therapeutics) - **Target customers**: B2B – physicians (rheumatology, primary care, pain management, neurology), hospitals, specialty distributors, and patients through prescription-based access. - **Mission or purpose statement**: “We listen, we develop, we deliver – so that patients feel seen, heard, and empowered to live fully again.” [tonixpharma.com](https://www.tonixpharma.com/) ## Products & Services - **TONMYA® (cyclobenzaprine HCl sublingual tablets)**: Approved in the U.S. (August 2025) and launched in November 2025 for the treatment of fibromyalgia in adults – the first new medicine for fibromyalgia in over 15 years. Non-opioid, centrally acting analgesic designed for bedtime dosing. [tonixpharma.com](https://www.tonixpharma.com/) - **Zembrace® SymTouch® (sumatriptan injection)**: FDA-approved prescription product for the treatment of acute migraine. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **Tosymra® (sumatriptan nasal spray)**: FDA-approved prescription product for acute migraine. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-102 SL (cyclobenzaprine HCl sublingual tablets)**: Investigational for Major Depressive Disorder (Phase 2 planned mid-2026) and Acute Stress Disorder/Reaction (Phase 2 enrolling, OASIS study at UNC funded by DoD). [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-4800 (anti-OspA monoclonal antibody)**: Seasonal prevention of Lyme disease – Phase 2 field study planned first half 2027. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-1500 (humanized anti-CD40L mAb)**: Phase 2-ready for prevention of kidney transplant rejection (investigator-initiated study expected mid-2026) and treatment of autoimmune diseases. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-1300 (double-mutant cocaine esterase)**: Phase 2 for cocaine intoxication; FDA Breakthrough Therapy designation. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-2900 (intranasal oxytocin + magnesium)**: For Prader-Willi Syndrome – Orphan Drug and Rare Pediatric Disease designations; Phase 2 planned Q1 2027. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-801 (horsepox live virus vaccine)**: Preclinical – mpox/smallpox protection; Phase 1 expected in 2027. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-4200 (small molecule anti-CD45)**: Broad-spectrum antiviral for biodefense; preclinical, supported by up to $34M DoD contract. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-1700 (TFF2-albumin fusion)**: Preclinical for gastric/colorectal cancer in combination with PD-1 blockade (in-licensed from Columbia University). [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) - **TNX-4900 (Sigma-1 receptor antagonist)**: Preclinical non-opioid analgesic for neuropathic pain. [10-K](https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf) ## Market Standing - **Valuation/Market Cap**: Not publicly available from provided sources (public stock; market cap fluctuates) - **Key Metric**: Annual Revenue – Not disclosed in provided sources (commercial launch of TONMYA began November 2025; earlier revenue from Zembrace/Tosymra). Total funding rounds not applicable for public company. R&D expenditures detailed in 10-K but not extracted. - **Notable Investors/Partners**: Almac Pharma Services (commercial supply for TONMYA) [10-K]; U.S. Department of Defense (DTRA contract up to $34M for TNX-4200) [10-K]; University of North Carolina (OASIS study for TNX-102 SL) [10-K]; Columbia University (TNX-1700 in-license) [10-K]. - **Growth Signals**: First FDA approval and launch of internally developed drug TONMYA (Nov 2025); expanding commercial payer coverage (second commercial agreement covering ~52M U.S. lives) [tonixpharma.com]; multiple Phase 2 programs advancing; ownership of two manufacturing facilities (RDC in Frederick, MD and ADC in Dartmouth, MA) [10-K]. ## Competitive Advantages - **First-mover in fibromyalgia**: TONMYA is the first new FDA-approved treatment for fibromyalgia in 15+ years, with a proprietary sublingual formulation that offers differentiated bioavailability and tolerability. - **Broad, diversified pipeline**: Covers CNS, immunology, infectious disease, and rare disease – reducing single-program risk and providing multiple shots on goal. - **In-house manufacturing**: Owned R&D Center (Frederick, MD) with BSL-2/3 capability and an Advanced Development Center (Dartmouth, MA) for live-virus vaccine and biologics production (currently decommissioned but ready for reactivation) [10-K]. - **Non-opioid focus**: All analgesic candidates (TONMYA, TNX-4900) are non-opioid, aligning with regulatory and societal trends away from opioids. - **Government partnerships**: DTRA contract for biodefense work (TNX-4200) provides non-dilutive funding and mission relevance. ## Strategic Focus - **Grow TONMYA**: Expand commercial coverage, physician adoption, and patient access for fibromyalgia treatment. - **Advance pipeline**: Initiate or complete Phase 2 studies for TNX-102 SL (MDD, ASD), TNX-4800 (Lyme), TNX-1500 (transplant rejection), TNX-1300 (cocaine intoxication), TNX-2900 (Prader-Willi), and move TNX-801 (mpox/smallpox vaccine) into Phase 1. - **Pursue strategic business development**: In-licensing, partnerships, and potential acquisitions to augment pipeline and commercial portfolio [10-K]. ## Why Work Here - **Culture**: The company emphasizes a collaborative, inclusive environment where every voice is heard. Mission-driven focus on “listening to patients’ lived experiences” and developing therapies for underserved, complex conditions. [tonixpharma.com/careers](https://www.tonixpharma.com/careers/) - **Work model**: Information on remote/hybrid policy not publicly available. Office and lab facilities in Berkeley Heights, NJ (HQ), Frederick, MD (R&D Center), and Dartmouth, MA (Advanced Development Center). - **Team & growth**: Opportunity to work on first-in-class drug launches (TONMYA) and cutting-edge science across multiple therapeutic areas. The company is at a pivotal stage transitioning from pure R&D to a commercial organization, offering varied career pathways. - **Benefits**: Equal opportunity employer; does not offer visa sponsorship for open positions. [tonixpharma.com/careers](https://www.tonixpharma.com/careers/) - **Notable perks/engineering culture**: Not detailed, but the science-driven environment with in-house manufacturing and government-funded biodefense work may appeal to researchers and engineers in pharma. ## Sources 1. [tonixpharma.com](https://www.tonixpharma.com/) – Company homepage, mission, product info, lat _…truncated._ ## Other roles at Tonix Pharmaceuticals - [Executive Assistant to the Chief Executive Officer](https://feeny.ai/job/executive-assistant-to-the-chief-executive-officer-tonix-pharmaceuticals-q21ne61fzfhr) — Berkeley Heights NJ OR New York, NY - [Regional Sales Director - California](https://feeny.ai/job/regional-sales-director-california-tonix-pharmaceuticals-california-8thn8v1c8d4r) — California - [Associate Medical Director, Clinical Development](https://feeny.ai/job/associate-medical-director-clinical-development-tonix-pharmaceuticals-berkeley-pa6mx85qwvws) — Berkeley Heights, NJ - [Manager, Financial Reporting](https://feeny.ai/job/manager-financial-reporting-tonix-pharmaceuticals-berkeley-heights-x4szc7r8yxkq) — Berkeley Heights, NJ - [Senior Associate, Supplier Quality](https://feeny.ai/job/senior-associate-supplier-quality-tonix-pharmaceuticals-north-dartmouth-ma-or-bfw25b7mxm0z) — North Dartmouth MA OR Berkeley Height, NJ - [Scientist II, In-Vitro & Nonclinical Assay Development](https://feeny.ai/job/scientist-ii-in-vitro-nonclinical-assay-development-tonix-pharmaceuticals-xfw3p1cqhsr3) — Frederick, MD - [Senior Manager, Information Security](https://feeny.ai/job/senior-manager-information-security-tonix-pharmaceuticals-frederick-md-or-062sk1rtyd2t) — Frederick MD OR Berkeley Heights, NJ - [​Pharmaceutical Management Rotational Program Associate​](https://feeny.ai/job/pharmaceutical-management-rotational-program-associate-tonix-pharmaceuticals-y27n7mcn4xq0) — Berkeley Heights, NJ - [Senior Specialist, Corporate Communications](https://feeny.ai/job/senior-specialist-corporate-communications-tonix-pharmaceuticals-berkeley-0rn9ax1k9r08) — Berkeley Heights NJ OR New York, NY - [Associate Director, Commercial Analytics & Sales Force Effectiveness](https://feeny.ai/job/associate-director-commercial-analytics-sales-force-effectiveness-tonix-21gmwfrwft16) — Berkeley Heights, NJ